In a first-of-its-kind sale of a U.S. law firm legal tech subsidiary to a private equity fund, New Jersey-based Porzio, Bromberg & Newman is offloading its compliance technology-focused Porzio Life Sciences unit to RLDatix for an undisclosed amount.

The firm launched the business that would become PLS 18 years ago, building a database to help clients track federal and state regulations governing the pharmaceutical industry. But with a fresh push into global compliance work, the company needed even more financial backing to fight for market share with large consulting firms, according to Vito A. Gagliardi Jr., who chairs the 90-lawyer firm.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]